From the Vault: The Heterogeneity of Atopic Dermatitis
Atopic dermatitis (AD) isn’t a single-symptom disease, and treating it like one may shortchange your patients. A focused review in a JDD February 2022 article highlights the many clinical faces of AD, from skin symptoms and lesion severity to disease course, comorbidities, and overall burden.
The takeaway? AD is a highly heterogeneous condition, and focusing on just one domain, like extent or itch, misses the full picture. Understanding and assessing the full spectrum of AD’s impact is essential for accurate severity grading and truly personalized care.
Dermatology providers are encouraged to think beyond surface symptoms and routinely integrate multiple clinical domains into their AD evaluations. This holistic approach can lead to better disease management and improved patient outcomes.
Now’s the time to shift from a narrow view of AD to a more nuanced, multidimensional approach. Your patients will feel the difference.
J Drugs Dermatol. 2022;21(2):172-176. doi:10.36849/JDD.6408
Blog write-up assisted by AI
